Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | U.S. biotech industry R&D expenses by region 2012-2014

U.S. biotech industry research and development expenses by region 2012-2014

U.S. biotech industry research and development expenses from 2012 to 2014, by geographic area (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays the research and development expenses of the United States biotech industry - represented by public biotech companies only from 2012 to 2014, sorted by (metropolitan) region. In New England, the R&D expense incurred by such companies came to some 5.3 billion USD in 2013.

San Francisco Bay Area 4664 5081 6883
New England 4172 5253 6487
Los Angeles/Orange County 3649 4375 4965
New Jersey 2030 2712 2973
New York State 981 1224 1863
San Diego 1301 1546 1677
Pacific Northwest 608 530 858
Mid-Atlantic 543 739 808
Pennsylvania/Delaware Valley 404 504 575
North Carolina 284 369 489
Southeast 172 202 239
Texas 154 174 237
Colorado 127 151 226
Midwest 220 197 193
Utah 59 61 85
Other 131 167 273